BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29574074)

  • 1. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf.
    Al-Rasadi K; Al-Zakwani I; Alsheikh-Ali AA; Almahmeed W; Rashed W; Ridha M; Santos RD; Zubaid M
    J Clin Lipidol; 2018; 12(3):685-692.e2. PubMed ID: 29574074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
    Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Herman R; Rohla M; Piackova E; Vargas KG; Farhan S; Freynhofer MK; Weiss TW; Huber K
    J Clin Lipidol; 2019; 13(1):115-122. PubMed ID: 30344049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.
    Al-Rasadi K; Alhabib KF; Al-Allaf F; Al-Waili K; Al-Zakwani I; AlSarraf A; Almahmeed W; AlSayed N; Alghamdi M; Batais MA; Almigbal TH; Alnouri F; Kinsara A; Hammouda A; Awan Z; Kary H; Elamin OA; Zadjali F; Al-Jarallah M; Shehab A; Sabbour H; Amin H; Altaradi H
    Curr Vasc Pharmacol; 2020; 18(1):57-64. PubMed ID: 30289081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of familial hypercholesterolemia in patients with myocardial infarction: A Chinese cohort study.
    Li S; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Qing P; Li XL; Sun J; Liu G; Dong Q; Xu RX; Cui CJ; Li JJ
    J Clin Lipidol; 2016; 10(6):1344-1352. PubMed ID: 27919351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Nanchen D; Gencer B; Muller O; Auer R; Aghlmandi S; Heg D; Klingenberg R; Räber L; Carballo D; Carballo S; Matter CM; Lüscher TF; Windecker S; Mach F; Rodondi N
    Circulation; 2016 Sep; 134(10):698-709. PubMed ID: 27462068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
    De Luca L; Arca M; Temporelli PL; Colivicchi F; Gonzini L; Lucci D; Bosco B; Callerame M; Lettica GV; Di Lenarda A; Gulizia MM;
    Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.
    Farnier M; Salignon-Vernay C; Yao H; Chague F; Brunel P; Maza M; Brunet D; Bichat F; Beer JC; Cottin Y; Zeller M
    J Clin Lipidol; 2019; 13(4):601-607. PubMed ID: 31324593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: Incidence, predictors, and outcomes.
    Kheiri B; Simpson TF; Osman M; Balla S; Rahmouni H; Mehta A; Pokharel Y; Nasir K; Fazio S; Shapiro MD
    J Clin Lipidol; 2021; 15(3):460-465. PubMed ID: 34053910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
    Alhabib KF; Al-Rasadi K; Almigbal TH; Batais MA; Al-Zakwani I; Al-Allaf FA; Al-Waili K; Zadjali F; Alghamdi M; Alnouri F; Awan Z; Kinsara AJ; AlQudaimi A; Almahmeed W; Sabbour H; Traina M; Atallah B; Al-Jarallah M; AlSarraf A; AlSayed N; Amin H; Altaradi H
    PLoS One; 2021; 16(6):e0251560. PubMed ID: 34086694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up.
    Auckle R; Su B; Li H; Xu S; Xie M; Song Y; Abdul Quddus M; Xu Y; Liu B; Che W
    PLoS One; 2017; 12(10):e0186815. PubMed ID: 29088271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study.
    Teramoto T; Sawa T; Iimuro S; Inomata H; Koshimizu T; Sakakibara I; Hiramatsu K
    Cardiovasc Ther; 2020; 2020():5936748. PubMed ID: 32636924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program.
    Danchin N; Farnier M; Zeller M; Puymirat E; Cottin Y; Belle L; Lemesle G; Cayla G; Ohlmann P; Jacquemin L; Perret T; Angoulvant D; Albert F; Ferrières J; Schiele F; Simon T;
    J Clin Lipidol; 2020; 14(3):352-360.e6. PubMed ID: 32527469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome.
    Hauguel-Moreau M; Aïdan V; Hergault H; Beauchet A; Pépin M; Prati G; Pillière R; Ouadahi M; Josseran L; Rodon C; Rabès JP; Charron P; Dubourg O; Massy Z; Mansencal N
    Arch Cardiovasc Dis; 2022 Feb; 115(2):87-95. PubMed ID: 35123917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Hypercholesterolemia Among Young Adults With Acute Coronary Syndrome.
    Haskiah F; Erez D; Khaskia A
    Am J Cardiol; 2023 Jan; 186():189-195. PubMed ID: 36270825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease.
    Nawaka N; Rattanawan C; Pussadhamma B; Wutthimanop A; Nuinoon M; Porntadavity S; Theansun W; Jeenduang N
    Postgrad Med; 2023 May; 135(4):410-417. PubMed ID: 36803651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipid profile, familial hypercholesterolemia prevalence, and 2-year cardiovascular outcome assessment in acute coronary syndrome: Real-life data of a retrospective cohort].
    Kayikcioglu M; Alan B; Payzın S; Can LH
    Turk Kardiyol Dern Ars; 2019 Sep; 47(6):476-486. PubMed ID: 31483296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.